Molecular epidemiology and genotype-specific disease severity of hepatitis E virus infections in Germany, 2010-2019.


Journal

Emerging microbes & infections
ISSN: 2222-1751
Titre abrégé: Emerg Microbes Infect
Pays: United States
ID NLM: 101594885

Informations de publication

Date de publication:
Dec 2022
Historique:
pubmed: 18 6 2022
medline: 20 7 2022
entrez: 17 6 2022
Statut: ppublish

Résumé

Zoonotic hepatitis E virus (HEV) is endemic in Europe. Genotype 3 (HEV-3) is predominant but information on subtype distribution, trends and clinical implications in Germany is scarce. We analysed 936 HEV RNA positive samples of human origin and corresponding national surveillance data from 2010 to 2019. Samples were referred to the National Consultant Laboratory and sequenced in at least one of four genomic regions. Sequences were analysed using bioinformatics methods and compared to the latest HEV reference set. 1,656 sequences were obtained from 300 female, 611 male and 25 of unknown sex aged 3-92 years (median 55 years). HEV-3c was predominant (67.3%) followed by HEV-3f, HEV-3e and HEV-3i(-like) with 14.3%, 9.7% and 4.0% (other subtypes ≤1.1%). The proportion of HEV-3 group 2 (3abchijklm) strains increased over time. Jaundice, upper abdominal pain, fever, hospitalization, and death due to HEV were significantly more often reported for patients infected with HEV-3 group 1 (3efg) compared to group 2. Larger spatio-temporal clusters of identical sequences were not observed. HEV-3 group 1 infections are more severe as compared to the predominant group 2. Detection of group 2 strains increased over the last years, possibly due to more frequent diagnosis of asymptomatic and mild courses. The diversity of strains and the space-time distribution is compatible with a foodborne zoonosis with supra-regional distribution of the infection vehicle (pork products).

Identifiants

pubmed: 35713010
doi: 10.1080/22221751.2022.2091479
pmc: PMC9295818
doi:

Substances chimiques

RNA, Viral 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1754-1763

Références

J Clin Virol. 2019 Nov;120:63-67
pubmed: 31590112
J Viral Hepat. 2022 May 2;:
pubmed: 35499211
PLoS One. 2019 Jun 7;14(6):e0216826
pubmed: 31173594
Infect Genet Evol. 2015 Oct;35:50-5
pubmed: 26218544
J Infect Dis. 2019 Jul 31;220(5):802-810
pubmed: 31107958
Viruses. 2019 May 28;11(6):
pubmed: 31141895
Euro Surveill. 2020 Sep;25(37):
pubmed: 32945256
J Virol Methods. 2006 Jan;131(1):65-71
pubmed: 16125257
Curr Protoc Bioinformatics. 2016 Mar 24;53:3.9.1-3.9.25
pubmed: 27010337
Liver Int. 2020 Feb;40(2):333-337
pubmed: 31837187
J Clin Virol. 2011 Sep;52(1):50-4
pubmed: 21742549
J Clin Med. 2020 Jan 24;9(2):
pubmed: 31991629
Epidemiol Infect. 2019 Jan;147:e224
pubmed: 31364564
Euro Surveill. 2018 May;23(19):
pubmed: 29766841
J Infect Dis. 2008 Dec 15;198(12):1732-41
pubmed: 18983248
J Hepatol. 2019 May;70(5):1023-1025
pubmed: 30803864
Mol Biol Evol. 2013 Apr;30(4):772-80
pubmed: 23329690
Liver Int. 2021 Jul;41(7):1462-1473
pubmed: 33960603
Front Microbiol. 2020 Sep 11;11:564486
pubmed: 33716992
J Virol Methods. 2012 Dec;186(1-2):157-60
pubmed: 22871672
Bioinformatics. 2014 May 1;30(9):1312-3
pubmed: 24451623
J Clin Virol. 2019 Nov;120:20-26
pubmed: 31536936
J Viral Hepat. 2018 Jun;25(6):752-758
pubmed: 29377436
Front Microbiol. 2020 Feb 05;11:137
pubmed: 32117156
J Gen Virol. 2020 Jul;101(7):692-698
pubmed: 32469300
Pathogens. 2020 Oct 11;9(10):
pubmed: 33050666
Rev Med Virol. 2018 Sep;28(5):e1987
pubmed: 29939461
Euro Surveill. 2019 Mar;24(10):
pubmed: 30862338
Emerg Microbes Infect. 2020 Dec;9(1):2697-2705
pubmed: 33251979
PLoS One. 2018 Jun 7;13(6):e0198045
pubmed: 29879148
Euro Surveill. 2019 Mar;24(10):
pubmed: 30862337
Transfusion. 2016 Mar;56(3):722-8
pubmed: 26559806
J Infect Dis. 2014 Apr 15;209(8):1212-8
pubmed: 24273173
Epidemiol Infect. 2014 Jul;142(7):1467-75
pubmed: 24054519
Viruses. 2021 Jun 29;13(7):
pubmed: 34209729
J Gen Virol. 2010 Mar;91(Pt 3):750-8
pubmed: 19889929
Emerg Infect Dis. 2017 Jul;23(7):1191-1193
pubmed: 28628452
Pathogens. 2020 Oct 20;9(10):
pubmed: 33092306
Food Environ Virol. 2021 Sep;13(3):337-346
pubmed: 33900549
Gastroenterology. 2016 Feb;150(2):355-7.e3
pubmed: 26551551

Auteurs

Mathias Schemmerer (M)

National Consultant Laboratory for HAV and HEV, Institute of Clinical Microbiology and Hygiene, University Medical Center Regensburg, Regensburg, Germany.

Jürgen J Wenzel (JJ)

National Consultant Laboratory for HAV and HEV, Institute of Clinical Microbiology and Hygiene, University Medical Center Regensburg, Regensburg, Germany.

Klaus Stark (K)

Department for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.

Mirko Faber (M)

Department for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH